Ascenda Test Menu
Ascenda BioSciences offers unique stool testing and biopsy panels, providing 28+ analytes. Our panels provide results for analytes individually, bundled, or comprehensively.
Improve Positive patient outcome
Stool testing & Biopsy Sample report
The GPX Panel includes 14 unique markers; bacteria, parasites, viruses.
Our multiplexed nucleic acid testing verifies the existence of pathogens with one stool specimen in a singular stool test.
The GPX is a multiplexed nucleic acid test that is designed to identify 14 various bacteria, parasites and viruses in the digestive system. Using this cutting edge PCR technology, this panel has the capability of detecting multiple pathogens within a single stool test run and provides the provider with sensitivity and specificity results of the highest standard. GPX test simultaneously detects and identifies the pathogens responsible for over 95% of cases of infectious diarrhea1. Indicated uses for GPX:
- Acute and chronic diarrhea
- All patients with symptoms and signs of infectious gastroenteritis or colitis
- Inpatient, outpatient and emergency settings
- Nosocomial surveillance
Specimen: Stool Testing DNA
Collection and transportation
Stool sample collected by the patient or client and transported in the provided DRG stool/biopsy container (10mL Saline-0.85% NaCl) at room temperature and extracted by DRG Laboratory.
Multiplex PCR (polymerase chain reaction) and hybridization technology When ordering the GPX test, you will receive a complete, easy to use stool testing collection kit that you return, postage-paid (US only), with your stool specimen. We process your specimen as soon as it is received in our state-of-the-art facility and provide your test results directly to your physician, usually within three to four business days. With advanced PCR technologies, it is possible to measure hundreds of organisms, literally taking billions of copies of an individual’s DNA. Please contact us at firstname.lastname@example.org or at (678)580-0613 – option 2.
CPT Code: 87507
(Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets)
|A03.0||Shigellosis due to Shigella dysenteriae|
|A04.0||Enteropathogenic Escherichia coli|
|A04.72||Enterocolitis due to Clostridium diff|
|K52.9||Noninfective gastroenteritis and colitis|
Helicobacter (H.Pylori) Panel
Our PCR based biopsy testing detection of Helicobacter pylori can serve as a powerful tool in diagnosis of Helicobacter pylori infection, and as a determinant for treatment efficacy.
- Helicobacter pylori (H. pylori)
CPT Code: 87338 – Detect agent nos dna amp (H. pylori)
|K27.0||Acute peptic ulcer, site unspecified, with hemorrhage|
|K27.1||Acute peptic ulcer, site unspecified, with perforation|
|K27.2||Acute peptic ulcer, site unspecified, with both hemorrhage and perforation|
|K27.3||Acute peptic ulcer, site unspecified, without hemorrhage or perforation|
|K27.4||Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage|
|K27.5||Chronic or unspecified peptic ulcer, site unspecified, with perforation|
|K27.6||Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation|
|K27.7||Chronic peptic ulcer, site unspecified, without hemorrhage or perforation|
|K27.9||Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation|
|K29.00||Acute gastritis without bleeding|
|K29.01||Acute gastritis with bleeding|
|K29.20||Alcoholic gastritis without bleeding|
|K29.21||Alcoholic gastritis with bleeding|
|K29.3||Chronic superficial gastritis|
|K29.4||Chronic atrophic gastritis|
|K29.5||Unspecified chronic gastritis|
The HP Panel does biopsy samples solely for H. Pylori, and whether it is active or not active.
The C.Diff Panel detects toxin A positive, toxin B positive, or both strains positive
C. Difficile ONLY, Panel
Our C. difficile only stool testing assay specifically detects toxin A positive or toxin B positive strains or both.
- C. difficile toxin A
- C. difficile toxin B
We test for Clostridium difficile using two molecular methodologies. First is the multiplex assay platform (see GPX Panel), that is designed to test for many GI pathogens (including C.difficile), parasites and viruses using PCR and DNA Hybridization methods on DNA extracted from patient stool testing samples. The second test is a C. difficile only assay, that specifically targets the C. difficile toxin A gene (tcdA) and toxin B gene (tcdB) with real-time PCR chemistry and is able to detect the presence of this bacterium from stool samples in just a few hours. With the C. difficile only Assay, we are able to specifically detect toxin A positive or toxin B positive strains or both. In house comparison studies have shown good correlation between the two methodologies in detecting C.difficile from patient stool testing samples. The two platforms of molecular testing allow for flexibility: 1) if the doctor requires only C.difficile testing or 2) a more expanded panel of analytes to be tested for a patient, they will able choose the platform to meet their requirements. When ordering the C. difficile only test, you will receive a complete, easy to use collection kit that you return, postage-paid (US only), with your stool specimen. We process your specimen as soon as it is received in our state-of-the-art facility and provide your test results directly to your physician, usually within three to four business days. With advanced PCR technologies, it is possible to measure hundreds of organisms, literally taking billions of copies of an individual’s DNA. Please contact us at email@example.com or at (678)580-0613 – option 2.
CPT Code: 87493 – C diff amplified probe (MUE-2)
|A04.71||Enterocolitis due to Clostridium difficile, recurrent|
|A04.72||Enterocolitis due to Clostridium difficile, not specified as recurrent|
|Z11.0||Encounter for screening for intestinal infectious Diseases|
|Z11.2||Encounter for screening for other bacterial Diseases|
GI Health Markers Panel
Our GI inflammatory health markers stool testing provides detailed information about possible inflammation that could occur in the digestive system.
Our GI inflammatory health markers are an invaluable resource for providers to determine the patient’s condition of Irritable Bowel Syndrome (IBS) or Inflammatory Bowel Disease (IBD). IBS and IBD are both chronic illnesses and share many of the same symptoms, however, each is treated differently. If not diagnosed correctly, serious effects could arise from both illnesses. Providers can select from our complete offering of protein markers to fully understand if inflammation exists throughout the entire digestive system. If providers are concerned with specific areas within the digestive system, individual markers can be selected for precise inflammation detection. These markers provide an abundance of information and has the highest sensitivity and specificity results of any digestive test available. When ordering the GI Health Markers test, you will receive a complete, easy to use collection kit that you return, postage-paid (US only), with your stool specimen. We process your specimen as soon as it is received in our state-of-the-art facility and provide your test results directly to your physician, usually within three to four business days. With advanced PCR technologies, it is possible to measure hundreds of organisms, literally taking billions of copies of an individual’s DNA. Please contact us at firstname.lastname@example.org or at (678)580-0613 – option 2.
|ICD-10 Code||Description||Associated Test|
|K58.0||Irritable Bowel Syndrome||Calprotectin|
|K90.0||Celiac disease||Anti-Gliadin/Fecal Fat|
|K90.41||Non-celiac gluten sensitivity||Anti-Gliadin/Fecal Fat|
|K29.0||Acute gastritis with bleeding||H. Pylori SA|
|K27.0||Acute peptic ulcer, site unspecified||H. Pylori SA|
|K80.10||Exocrine pancreatic insufficiency||Elastase|
|K85.10||Other specified diseases of pancreas||Elastase|
The GHM Panel looks for GHM's only. This panel encompasses a wide variety of markers.
The AR Panel looks for AR's only. This panel was designed to include the most commonly used antibiotics today.
Antibiotic Resistance Panel
In our Antibiotic Resistance Panel stool testing we assess Antibiotic Resistant genes in patient stool samples, using molecular methods that offer several advantages
- ß-lactamase (bla-TEM)
- Nitroimidazole (nimD)
- Imidazole (nimA)
- Vancomycin (vanA)
- Vancomycin (vanB)
- Fluoroquinolones (qnr)
Molecular methods that detect genes directly involved in the resistance of an organism to a particular agent offer a more straightforward prediction of antibiotic resistance.
CPT Code: 87798 – Detect agent nos dna amp MUE(6)
|Z16.12||Extended spectrum beta lactamase (ESBL) resistance|
|Z16.19||Resistance to other specified beta lactam antibiotics|
|Z16.21||Resistance to vancomycin|
|Z16.22||Resistance to vancomycin related antibiotics|
|Z16.23||Resistance to quinolones and fluoroquinolones|
|Z16.24||Resistance to multiple antibiotics|
|Z16.29||Resistance to other single specified antibiotic|
|Z16.31||Resistance to antiparasitic drug(s)|
|Z16.32||Resistance to antifungal drug(s)|
|Z16.33||Resistance to antiviral drug(s)|
|Z16.34||Resistance to antimycobacterial drug(s)|
|Z16.341||Resistance to single antimycobacterial drug|
|Z16.342||Resistance to multiple antimycobacterial drugs|
|Z16.35||Resistance to multiple antimicrobial drugs|
|Z16.39||Resistance to other specified antimicrobial drug|
|Z16.12||Extended spectrum beta lactamase (ESBL) resistance|
The Full Panel includes the GPX, AR, GHM, and HP panels. C. Diff A/B is included in the GPX and Full panel options. If you need to determine between C. Diff A and B, you will want to order the C. Diff only panel as listed above.